Inventor
SCHOLZ ARNE
DE30 patents
⚠️ This page may combine multiple inventors who share the name “SCHOLZ ARNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
Bayer Pharma AG
14 patentsUS9963464B2May 8, 2018
Macrocyclic compounds
Bayer Pharma AG2 citations71
US10717749B2Jul 21, 2020
Macrocyclic sulfondiimine compounds
Bayer Pharma AG2 citations70
US10214542B2Feb 26, 2019
Modified macrocyclic compounds
Bayer Pharma AG2 citations61
US9790189B2Oct 17, 2017
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
Bayer Pharma AG1 citations52
US9499492B2Nov 22, 2016
4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group
Bayer Pharma AG1 citations52
US10124007B2Nov 13, 2018
Combination of PI3K-inhibitors
Bayer Pharma AG0 citations51
US9877954B2Jan 30, 2018
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
Bayer Pharma AG1 citations51
US9670161B2Jun 6, 2017
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
Bayer Pharma AG0 citations51
US9650340B2May 16, 2017
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
Bayer Pharma AG1 citations51
US9770445B2Sep 26, 2017
Sulfoximine substituted 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives and their use as CDK9 kinase inhibitors
Bayer Pharma AG0 citations48
US9856242B2Jan 2, 2018
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
Bayer Pharma AG0 citations42
US9902716B2Feb 27, 2018
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone group
Bayer Pharma AG0 citations41
US9884849B2Feb 6, 2018
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine group
Bayer Pharma AG0 citations41
US9708293B2Jul 18, 2017
N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
Bayer Pharma AG0 citations41
Lücking Ulrich
4 patentsUS9133171B2Sep 15, 2015
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
Lücking Ulrich5 citations72
US9669034B2Jun 6, 2017
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
Lücking Ulrich2 citations71
US8916557B2Dec 23, 2014
Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines
Lücking Ulrich4 citations71
US9108926B2Aug 18, 2015
Disubstituted 5-fluoro-pyrimidines
Lücking Ulrich1 citations51
EIS KNUT
3 patentsBAYER AG
3 patentsUS10981932B2Apr 20, 2021
Macrocyclic indole derivatives
BAYER AG9 citations83
US11492358B1Nov 8, 2022
Macrocyclic indole derivatives
BAYER AG3 citations71
US11701347B2Jul 18, 2023
Use of 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine for treating diffuse large B-cell lymphoma
BAYER AG0 citations62
LIU NINGSHU
3 patentsUS9278925B2Mar 8, 2016
Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one
LIU NINGSHU3 citations71
US9000026B2Apr 7, 2015
Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy
LIU NINGSHU2 citations61
US9212140B2Dec 15, 2015
(5s,8s)-3-(4′-chlor-3′-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5] dec-3-en-2-one (compound A) for treatment
LIU NINGSHU0 citations49